ArticleClinical, cosmetic and investigational dermatology2025
Severe Unilateral Alopecia in a Long-Term Surviving Male Adolescent Glioblastoma Multiforme Patient.
Article in Clinical, cosmetic and investigational dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Radiation-induced alopecia (RIA) typically presents as transiently or persistently non-scarring alopecia with a distinct geometric pattern, and minoxidil sometimes serves as an effective therapeutic agent. However, there have been no reported cases of severe unilateral alopecia following radiotherapy for pediatric glioblastoma multiforme (p-GBM), that was unresponsive to minoxidil treatment. Case Report: This case presents a 17-year-old male with severe unilateral alopecia, who was diagnosed with glioblastoma multiforme (GBM) and consequently received radiochemotherapy. Remarkably, he has survived beyond three years without evidence of tumor recurrence, but with the sole persistent issue being the left-sided alopecia. Despite intensive therapeutic interventions comprising 12 months of topical 5% minoxidil therapy (twice daily) combined with three courses of platelet-rich plasma (PRP) injections administered at 4-week intervals, the alopecic area showed no significant improvement and eventually progressed to permanent alopecia. Conclusion: The prevention and treatment of RIA remain poorly understood, and this clinical scenario urgently necessitates the exploration of novel therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.